Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR548A1 host gene (MIR548A1HG) is a non-coding RNA gene that serves as the primary transcript for microRNA 548a-1 (miR-548a-1). MicroRNAs processed from this gene are involved in post-transcriptional regulation of gene expression, affecting mRNA stability and translation. Although not a conventional therapeutic target, the miRNA it produces may participate in pathways involving immunity, cell signaling, and disease modulation. For example, miR-548ah, part of the same family, can target IFN-γ receptor 1, potentially impacting immune signaling in chronic hepatitis B[1][2][3][4].
Not applicable; however, miR-548a-1, spawned by this gene, can regulate mRNA targets via post-transcriptional silencing (e.g., downregulating IFN-γ receptor 1 in chronic hepatitis B[1])
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR548A1 host gene (MIR548A1HG).